CCL4 Enhances Preosteoclast Migration and Its Receptor CCR5 Downregulation by RANKL Promotes Osteoclastogenesis

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-0562-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation

Frontiers in Immunology
AllergyImmunology
2019English

Glechoma Hederacea Suppresses RANKL-mediated Osteoclastogenesis

Journal of Dental Research
Dentistry
2014English

Puerarin Inhibits the Osteoclastogenesis by Inhibiting RANKL-dependent and –Independent Autophagic Responses

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

RANKL-Independent Osteoclastogenesis: A Long-Standing Controversy

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

NAC1 Promotes the Migration of Prostate Cancer Cells and Participates in Osteoclastogenesis by Negatively Regulating IFNβ

Oncology Letters
Cancer ResearchOncology
2017English

CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling

Journal of Neuroscience
Neuroscience
2019English

Novel RANKL DE-loop Mutants Antagonize RANK-mediated Osteoclastogenesis

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2017English

The Molecular Mechanism of Osteoclastogenesis: ODF/RANKL-dependent and Independent Pathways

Arthritis Research & Therapy
2001English

Lipopolysaccharide-Stimulated Osteoclastogenesis Is Mediated by Tumor Necrosis Factor via Its P55 Receptor.

Journal of Clinical Investigation
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy